Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-25

FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)

View source ↗

Summary

FDA approved a supplemental application for VERSACLOZ (clozapine) from TruPharma LLC, updating the labeling per the supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VERSACLOZ (CLOZAPINE)

Snippet

SUPPL AP for VERSACLOZ (CLOZAPINE)